Docebo
DCBO · TORONTO
About DCBO
- Employees
- 900
- Headquarters
- TORONTO, Ontario
- Listed
- Oct 8, 2019
- Sector
- Information Technology
- Industry
- Software
- Website
- docebo.com
DCBO key statistics
- Market cap
- 1.06B
- Price-earnings ratio
- 26.31
- Dividend yield
- —
- Average volume
- 39.34K
- Volume
- 31.81K
- Open price
- $30.66
- High today
- $31.16
- Low today
- $30.57
- 52 Week high
- $31.27
- 52 Week low
- $14.39
Docebo (DCBO) at a glance
As of Oct 23, 2026, Docebo (DCBO) shares are priced at $30.91, giving the company a market cap of 1.06B and a price-to-earnings ratio of 26.31.
Today the stock has traded between $30.57 and $31.16. The current price is 1.1% above the day's low and 0.8% below its high.
Volume so far is 31.81K shares, in line with the average of 39.34K shares a day.
Over the past year Docebo has ranged from $14.39 to $31.27, and now sits 98% of the way up that range.
Docebo met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.35 per share against an estimate of $0.3188.
The average analyst price target is $21.00, 32.1% below the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy85.7%
- Hold14.3%
- Sell0.0%
- Low
- $15.06
- Now
- $30.91
- High
- $28.26
DCBO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 37.5% on average.
- Q3 FY24: reported $0.16 per share against an estimate of $0.2142
- Q4 FY24: reported $0.38 per share against an estimate of $0.1598
- Q1 FY25: reported $0.27 per share against an estimate of $0.2142
- Q2 FY25: reported $0.29 per share against an estimate of $0.2264
- Q3 FY25: reported $0.34 per share against an estimate of $0.3366
- Q4 FY25: reported $0.45 per share against an estimate of $0.3672
- Q1 FY26: reported $0.34 per share against an estimate of $0.3451
- Q2 FY26: reported $0.35 per share against an estimate of $0.3188
DCBO news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Docebo Releases The 2027 Skills Intelligence Report
- Press releaseBusiness Wire
Docebo Inc. Announces Final Results of its Substantial Issuer Bid
- Press releaseBusiness Wire
Docebo Inc. Announces Preliminary Results of its Substantial Issuer Bid
- Press releaseBusiness Wire
Docebo Inc. Announces Substantial Issuer Bid Price Increase and Extension
- Press releaseBusiness Wire
Docebo Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Docebo Announces Participation in Upcoming Investor Conferences in August and September
- Press releaseBusiness Wire
Docebo Inc. Announces Commencement of Previously Announced Substantial Issuer Bid
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.